DK1531839T3 - Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet - Google Patents

Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet

Info

Publication number
DK1531839T3
DK1531839T3 DK03760696.9T DK03760696T DK1531839T3 DK 1531839 T3 DK1531839 T3 DK 1531839T3 DK 03760696 T DK03760696 T DK 03760696T DK 1531839 T3 DK1531839 T3 DK 1531839T3
Authority
DK
Denmark
Prior art keywords
aggressiveness
anxiety
pheromones
soothing
bird
Prior art date
Application number
DK03760696.9T
Other languages
Danish (da)
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of DK1531839T3 publication Critical patent/DK1531839T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK03760696.9T 2002-06-19 2003-06-19 Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet DK1531839T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
DK1531839T3 true DK1531839T3 (da) 2010-09-13

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03760696.9T DK1531839T3 (da) 2002-06-19 2003-06-19 Beroligende fugle-feromoner til nedsættelse af stress, angst og aggressivitet

Country Status (12)

Country Link
EP (1) EP1531839B1 (enExample)
JP (1) JP4863619B2 (enExample)
CN (1) CN100508968C (enExample)
AT (1) ATE468123T1 (enExample)
AU (1) AU2003246372B8 (enExample)
BR (1) BRPI0311934B1 (enExample)
CA (1) CA2490681C (enExample)
DK (1) DK1531839T3 (enExample)
ES (1) ES2345099T3 (enExample)
MX (1) MXPA04013005A (enExample)
PT (1) PT1531839E (enExample)
WO (1) WO2004000336A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6629286B2 (ja) 2014-03-18 2020-01-15 アンスティテュ・ドゥ・ルシェルシュ・アン・セミオシミー・エ・エソロジー・アプリケＩｎｓｔｉｔｕｔ Ｄｅ Ｒｅｃｈｅｒｃｈｅ Ｅｎ Ｓｅｍｉｏｃｈｉｍｉｅ Ｅｔ Ｅｔｈｏｌｏｇｉｅ Ａｐｐｌｉｑｕｅｅ ネコ鎮静フェロモン
CA2974867A1 (en) * 2015-02-20 2016-08-25 Nestec S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) * 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
EP3727457B1 (fr) 2017-12-22 2025-08-20 Ceva Santé Animale Diffuseurs de composition de semio-chimiques régulés en fonction de la température
CN117919345A (zh) * 2023-12-21 2024-04-26 宁波三生生物科技股份有限公司 一种信息素组合物及其制备方法
CN120938981A (zh) * 2025-10-20 2025-11-14 宁波三生生物科技股份有限公司 一种信息素组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
BR9917806B1 (pt) * 1998-01-21 2013-06-18 composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço.
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
EP0948963B1 (en) * 1998-01-21 2003-05-07 Fideline Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
ES2314157T3 (es) * 1998-11-02 2009-03-16 Gilead Sciences, Inc. Terapia de combinacion para tratar el virus de la hepatitis b.

Also Published As

Publication number Publication date
PT1531839E (pt) 2010-07-21
CA2490681A1 (en) 2003-12-31
CA2490681C (en) 2012-01-24
ATE468123T1 (de) 2010-06-15
AU2003246372A1 (en) 2004-01-06
CN100508968C (zh) 2009-07-08
EP1531839B1 (en) 2010-05-19
JP2006508038A (ja) 2006-03-09
AU2003246372B2 (en) 2008-11-27
EP1531839A1 (en) 2005-05-25
JP4863619B2 (ja) 2012-01-25
CN1668318A (zh) 2005-09-14
ES2345099T3 (es) 2010-09-15
BR0311934A (pt) 2005-04-05
MXPA04013005A (es) 2005-09-12
BRPI0311934B1 (pt) 2015-05-26
AU2003246372B8 (en) 2009-03-26
WO2004000336A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
DK1047415T3 (da) Pheromoner, der beroliger svin, til reduktion af stress, angst og aggressivitet
ATE397936T1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
UY29007A1 (es) Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
AR047529A1 (es) Compuestos de quinolina sustituidos
CY1116700T1 (el) Παρασκευη συνθετικου χολικου οξεος
EA200700382A1 (ru) Фунгицидные композиции
CL2012002705A1 (es) Composicion farmaceutica que comprende: a) 0,1-20% de ropivacaina,bupivacaina o levobupivacaina, b) 15 a 70% en peso de un monoglicerido de acido graso de cadena larga o sus mezclas, c) 5 a 60% de un acido graso libre saturado o instaurado de cadena larga y d)menos de 30% de agua; uso para reducir el dolor.
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
MX2019012681A (es) Composiciones nutricionales y farmaceuticas encapsuladas.
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
BRPI0510526A (pt) formulações lìquidas estabilizadas de interferon
ATE474547T1 (de) O/w emulsion zur pflege der hand
ATE468123T1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
NO20084478L (no) Konjugerte lipidderivater
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
ATE406415T1 (de) Silikonmemulsion, verfahren zu ihrer herstellung und kosmetischer bestandteil
DE60219148D1 (de) Pharmazeutische Zusammensetzung zur Verhinderung der Entwicklung und Progression von mykotischen Hautoberflächenerkrankungen
BRPI0415163A (pt) composição de xampu e usos de uma combinação de cera de abelha e silicone
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
EP1131338A4 (en) PROCESS FOR PRODUCING HIGHLY PURIFIED INVASINATED PROTEIN AND USE OF SUCH PROTEIN
DK1735005T3 (da) Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SV2006002122A (es) Prodrogas de estriol y estetrol ref. p-sv-78.343/msu
ATE374811T1 (de) Hühner-astrovirus typ 2